Physiomics reports fall in operating loss, rise in turnover

UK biology company Physiomics said operating loss dropped 6.3 per cent in the last half of 2012 as the group signed on new clients and progressed in research and development of products.

UK biology company Physiomics said operating loss dropped 6.3 per cent in the last half of 2012 as the group signed on new clients and progressed in research and development of products.

Operating loss came to £307,685, compared to £328,674 for the same period a year ago, as turnover increased 52.9% to £52,000.

The firm said it signed on a "top five" global pharmaceutical client during the period and was in discussions with others about licencing technology and entering into long-term contracts.

A £4.0m Standby Equity Distribution Agreement was signed with Yorkville, strengthening the position of the company for future growth and acquisition.

Physiomics advanced in developing two new technologies - DrugCARD database and Cardiac toxicity prediction service - which will be launched this year.

First stage of development of the group's Virtual Tumour Clinical, a computer model which analyses tumour cells, is underway as the company works closely with drug discovery and development groups.

"Significant progress has been made during the half year," the group said.

"The customer base has been increased, relationships with existing customers are progressing, new products are soon to come on line and the company's flagship Virtual Tumour Clinical project has begun in earnest, with large pharma already showing an interest in assisting its development.

"While progress on the sales front has been slower than the directors hoped, they believe that the company is establishing the level of credibility required to convert more prospects and is well positioned to deliver more stable sales in the near-term. Successful launch of Virtual Tumour Clinical has the potential to achieve a step-change in growth of revenues."

Shares rose 8.33% to 0.13 at 09:44 Thursday.

RD

Recommended

Share tips of the week – 22 October
Share tips

Share tips of the week – 22 October

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
22 Oct 2021
Three dividend stocks from the dynamic Asia/Pacific region
Share tips

Three dividend stocks from the dynamic Asia/Pacific region

Professional investor Sat Duhra of the Henderson Far East Income investment trust highlights three of his favourite stocks.
18 Oct 2021
Share tips of the week – 15 October
Share tips

Share tips of the week – 15 October

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
15 Oct 2021
Trading: stash the family cash in this cheap wealth management firm
Trading

Trading: stash the family cash in this cheap wealth management firm

Wealth management is a growth market. Rathbone Brothers should be a prime beneficiary – and looks cheap. Matthew Partridge explains the best way to pl…
12 Oct 2021

Most Popular

How to invest as we move to a hydrogen economy
Energy

How to invest as we move to a hydrogen economy

The government has started to roll out its plans for switching us over from fossil fuels to hydrogen and renewable energy. Should investors buy in? St…
8 Oct 2021
Properties for sale for around £1m
Houses for sale

Properties for sale for around £1m

From a stone-built farmhouse in the Snowdonia National Park, to a Victorian terraced house close to London’s Regent’s Canal, eight of the best propert…
15 Oct 2021
How to invest in SMRs – the future of green energy
Energy

How to invest in SMRs – the future of green energy

The UK’s electricity supply needs to be more robust for days when the wind doesn’t blow. We need nuclear power, says Dominic Frisby. And the future of…
6 Oct 2021